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STATEMENT
Radiology in the era of value-based 
healthcare: a multi-society expert statement 
from the ACR, CAR, ESR, IS3R, RANZCR, 
and RSNA
Adrian P. Brady1,13*, Jaqueline A. Bello2,14, Lorenzo E. Derchi3,13, Michael Fuchsjäger4,13, Stacy Goergen5,15, 
Gabriel P. Krestin6,16, Emil J. Y. Lee7,17, David C. Levin8,18†, Josephine Pressacco9,17, Vijay M. Rao8,18, 
John Slavotinek10,15, Jacob J. Visser6,16, Richard E. A. Walker11,17 and James A. Brink12,14,16
Abstract 
Background: The Value-Based Healthcare (VBH) concept is designed to improve individual healthcare outcomes 
without increasing expenditure, and is increasingly being used to determine resourcing of and reimbursement for 
medical services. Radiology is a major contributor to patient and societal healthcare at many levels. Despite this, some 
VBH models do not acknowledge radiology’s central role; this may have future negative consequences for resource 
allocation.
Methods, findings and interpretation: This multi-society paper, representing the views of Radiology Societies in 
Europe, the USA, Canada, Australia, and New Zealand, describes the place of radiology in VBH models and the health-
care value contributions of radiology. Potential steps to objectify and quantify the value contributed by radiology to 
healthcare are outlined.
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Key points
• Value-based healthcare (VBH) is a framework for 
improving individual patient health outcomes per 
unit of expenditure.
• Radiology is a key component of healthcare, impact-
ing greatly on patient outcomes, and must be consid-
ered a vital element of VBH.
• Embracing VBH principles, radiology can contribute 
to moving to a value-driven system, where all inves-
tigations or interventions contribute positively to 
patient outcomes.
Introduction
In September 2020, members of this writing group pub-
lished an article in JAMA on Radiology and Value-Based 
Healthcare [1], intended to raise awareness among non-
radiologists of the value contributed to healthcare by 
radiology, and of ways that value can be harnessed and 
enhanced by those who utilise and those who deliver 
radiology services. This paper expands on that publica-
tion, in order to further explore the issues surrounding 
value-based healthcare as they involve radiology, and is 
primarily aimed at a radiology readership.
Value-based healthcare (VBH) has emerged in recent 
years as a framework for improving individual patient 
health outcomes per unit of expenditure [2, 3]. The impe-
tus for this is, at least in part, the inexorable worldwide 
rise in healthcare usage volume and associated costs, 
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cost-of-living inflation. The thrust of the VBH concept 
is to continue to improve individual health outcomes 
without commensurate increasing expenditure, by focus-
ing on identification of practices that optimise the ratio 
between health gained and healthcare cost. The goal is to 
ensure that inflation does not make current healthcare 
systems unsustainable, while maintaining or continually 
improving patient outcomes.
US medical service funding is already influenced by 
traditional cost-effectiveness analyses (CEA) and the 
more recent VBH concept, as well as the related, but not 
necessarily aligned, value-based payment (VBP) mod-
els [4]. CEA focuses on a single metric (incremental cost 
effectiveness ratio, ICER) and is commonly used by poli-
cymakers to inform population—level decisions about 
which procedures, pharmaceuticals or devices will be 
funded or subsidised. “Value” in the context of VBH, on 
the other hand, focuses on what is of value to the indi-
vidual during a particular episode of care and its immedi-
ate aftermath. Consequently, it remains less well-defined, 
with a wide range of proposed metrics. These patient-
centred metrics are, in turn, not necessarily aligned with 
VBPs (e.g. US Medicare and Medicaid Value-Based Pay-
ment Modifier), which often focus on short-term costs 
to a specific payer of an episode of care. Criticisms of 
such systems revolve around their inability to accurately 
measure important patient outcomes and their potential 
to exacerbate existing disparities in care delivery without 
improving physician performance of healthcare delivery 
[5].
The European Commission Expert Panel on Effective 
Ways of Investing in Health has recently published a draft 
Opinion Paper on “Defining Value in ‘value-based health-
care’”, which seeks to move the discussion away from 
value-based pricing to a broader definition of VBH, based 
on four pillars:
• appropriate care to achieve patients’ personal goals 
(personal value)
• achievement of best possible outcomes with available 
resources (technical value)
• equitable resource distribution across all patient 
groups (allocative value)
• contribution of healthcare to social participation and 
connectedness (societal value) [6]
Whatever the source of funding in any individual coun-
try, it is likely that healthcare institutions will be obliged 
in the future to demonstrate that they apply VBH princi-
ples and optimise resource utilisation in order to ensure 
continued funding. Therefore, not only is VBH a sensi-
ble approach to guide critical assessment of practices; it 
also will be key to services maintaining future financial 
viability.
This paper, written by representatives of the European 
Society of Radiology (ESR), American College of Radi-
ology (ACR), Radiological Society of North America 
(RSNA), Canadian Association of Radiologists (CAR), 
Royal Australian and New Zealand College of Radiolo-
gists (RANZCR) and International Society for Strate-
gic Studies in Radiology (IS3R), seeks to outline the 
value contributed to healthcare by radiology, and to 
explain how that value may be measured, recognised and 
augmented.
Value‑based healthcare models
Porter’s original description of a VBH model listed an 
outcome measure hierarchy containing three tiers (Sus-
tainability of Health, Process of Recovery & Health Sta-
tus achieved or retained), with many factors contributing 
to each tier. The top tier (Sustainability) is considered 
the most important, with lower-tier outcomes involv-
ing results contingent on higher-tier success [8]. In his 
2010 NEJM paper outlining this model, Porter acknowl-
edged that medical care “involves multiple medical spe-
cialties and numerous interventions”, and that “[m]uch 
of the total cost of caring for a patient involves shared 
resources, such as physicians, staff, facilities, and equip-
ment” [7]. When calculations of value are used as a basis 
for resourcing or reward, conflicts can develop between 
different groups of contributors to care [1]. Porter writes: 
“in a well-functioning health care system, the creation of 
value for patients should determine the rewards for all 
other actors in the system” [7].
Radiology is a vital part of modern medicine, a signifi-
cant positive contributor to patient diagnosis and con-
tinuing care, and thus a key component of provision of 
value. Furthermore, radiology as a specialty is the perfect 
example of a healthcare resource shared across all levels 
of healthcare delivery, all medical specialties, and patient 
care at all ages [1]. Diagnostic radiology contributes value 
in clinical workup by refining differential diagnoses for-
mulated from history-taking, physical examination and 
sometimes laboratory test results, thereby decreasing 
the time required to initiate appropriate treatment, ulti-
mately helping to reduce patient morbidity and mor-
tality [8, 9]. In Porter’s VBH model, health gains and 
reduced costs associated with decreased time in hospi-
tal, improved survival and lower utilisation of ineffective 
treatments and investigations are not recognised as con-
tributions made by radiology to the value of healthcare. 
Nonetheless, short-term expenditures on imaging may 
create long-term and system-wide cost savings and better 
patient outcomes, none of which are credited to the value 
of radiology according to this model.
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One extreme interpretation of the VBH model con-
siders diagnostic radiology as a “cost centre”, whereby 
all expenditures on imaging are perceived to negatively 
contribute to value in healthcare, in the context of the 
influence of errors or complications negatively affecting 
outcomes in the Process of Recovery tier. Errors happen 
in radiology, as they do in all branches of medicine, but 
many reports of errors in radiology misunderstand the 
diagnostic process, and apply biases to interpretation 
after the fact, rather than reflecting the reality of inter-
pretation of imaging data at a specific time, often based 
on limited background information [3, 10]. This extreme 
view values radiology’s contributions (if at all) in much 
the same way as laboratory investigation outputs, ignor-
ing much of the value created by the practice of radiol-
ogy, and radiology’s clinical centrality to patient care.
Radiology’s place in value‑based healthcare 
models
How, then, can we ensure that radiology is appreciated 
not as a potential source of loss of value, but rather as an 
intrinsic value creator?
The most important way to do this is to quantify radiol-
ogy’s impact on patient outcomes and on measurements 
used historically by policymakers and other third party 
payers, such as Quality Adjusted Life Years (QALYs) 
and ICERs. In 1991 Fryback and Thornbury proposed a 
6-level hierarchical value model starting with evidence 
of technical efficacy at the lowest level and ending with 
societal efficacy at the highest level [11] (Fig. 1). It is gen-
erally considered that adding value to patient care only 
starts at level 4. However, much scientific literature relat-
ing to diagnostic radiology (as opposed to image-guided 
therapy) relates to image acquisition and diagnostic accu-
racy, at levels 1 and 2, rather than to the contribution of 
radiology, in concert with the entire system of delivery of 
care, to the health outcomes of the patient or society as a 
whole (the higher hierarchical levels). For instance, a high 
quality MRI performed on well—maintained equipment 
by a highly trained radiologist for a previously well 42—
year old patient reporting two weeks of non-specific low 
back pain (effective at levels 1 & 2) may provide less net 
benefit to individual or societal health than an average 
quality head CT for a 25 year old painter who fell from a 
Fig. 1 Hierarchical value model. (Reproduced with permission from Raja UA, Patel S, Singh LK, Shah D, Hamdulay S, Penn H, Remedios D. Early 
arthritis ultrasound: a 4-year outcome study. ECR 2014, EPOS, https ://doi.org/10.1594/ecr20 14/C-2059)
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ladder and has a high pre-test clinical risk of intracranial 
injury (effective at levels 3–6) [11].
Diagnostic Radiology faces special challenges in dem-
onstrating a link between its key output, (making or 
changing a diagnosis), and the final step in the value 
chain, (improved health of the patient), due to the many 
confounders along the pathway between diagnosis and 
outcome.
Pathways exist for radiology providers to demonstrate 
meaningful contributions to patient health outcomes, 
or to have their funding/reimbursement influenced by 
value-based activity. The US Medicare Access and CHIP 
Reauthorization Act of 2015 (MACRA) established the 
Quality Payment Program, under which eligible clini-
cians can participate via one of two tracks: Advanced 
Alternative Payment Models (APMs); or the Merit-based 
Incentive Payment System (MIPS). Both tracks involve 
quality measures that demonstrate participation in cer-
tain quality improvement activities as well as contribu-
tions of radiology activity to patient care [12].
Considering the issues underpinning radiology value is 
not a new idea. In 2009, Gunderman & Boland elegantly 
outlined some of the reasons physicians or patients 
might choose to use one radiology service over another 
(perceived relative value), and some of the questions 
radiologists might ask themselves when considering the 
value they provide to patients [13]. In 2011, Rao & Levin 
explained the value-based benefits to patients of sin-
gle, cohesive, on-site radiology groups in hospitals, as 
opposed to fragmented or out-sourced imaging services 
[14]. Also in 2011, Gazelle et al. [15] proposed a frame-
work to assess the value of diagnostic imaging in the 
era of comparative effectiveness research. In 2016 Sei-
del et al. [16] described specific strategies for diagnostic 
imaging to generate evidence and value.
Nobody in modern medical practice could imagine 
attempting to function and maintain standards of clini-
cal service in the absence of diagnostic imaging services, 
including specialist radiologist interpretation, consulta-
tion and intervention. Radiology is a deeply-embedded 
and essential part of modern patient care, at all levels of 
service delivery and complexity, encompassing high-level 
hospital-based medicine, primary care investigation, 
screening and health-promotion activities. “Few episodes 
of care occur without medical imaging, and a rational 
health care system should define the distribution of reve-
nue to radiology based on its value as derived from qual-
ity and costs” [17].
Radiology departments have the potential to be bottle-
necks in any healthcare environment. A secondary analy-
sis of the US National Hospital Ambulatory Medical Care 
Survey (NHAMCS) from 2006 through 2008 demon-
strated that when a physician ordered an ultrasound, CT, 
or MRI during an emergency department visit, the aver-
age length of stay for that patient increased by 56, 59, and 
64 min respectively [18]. Under-resourced hospital-based 
services can delay patient throughput and discharge. 
Under-resourced primary-care and out-patient access to 
imaging limits the capacity of non-hospital-based ser-
vices to manage patients, resulting in increased reliance 
on more expensive hospital-based facilities. Adequate 
resourcing of radiology is vital to achieving or maintain-
ing healthcare efficiency, and thus to maximising value. 
Therefore, as part of the fundamental goal of enhance-
ment of value for patients, radiology must be a compo-
nent of any formula to assess costs against outcomes in 
healthcare.
Value equation
Relating technical quality, service quality and price has 
been defined as the radiology “value equation” [19]. 
What constitutes value in healthcare depends upon 
who you ask. The University of Utah Health surveyed 
patients, physicians and employers who pay for medical 
benefits, in an effort to define how they perceive value. 
Each group prioritised different value statements, reflect-
ing the different viewpoints of those who deliver a ser-
vice, those who receive it and those who pay for it [20]. 
This led the authors to propose a shift from the original 
Porter equation (Value = Outcome/Cost) to a more-
nuanced one, identifying service as a specific compo-
nent (Value = Quality + Service/Cost). Quality may 
incorporate elements such as employee productivity (for 
employers) that matter little to other groups. Service may 
include elements such as out-of-pocket expenses (for 
patients) that are not prime considerations for physicians 
or employers.
Value exists as a concept only in the eyes of the recipi-
ent. In economic terms, it can be considered as the total 
amount of money a customer would be willing to pay for 
a service. Value creation involves providing new services 
or improving existing services to increase their worth to 
the recipient, at little or no additional cost [19].
Where is the value of radiology delivered?
(a) Prevention
(a) Disease prevention (screening and predictive 
imaging biomarkers)
(b) Reassurance, e.g. confirmation of the absence 
of disease, eliminating the need for further 
(potentially-expensive) investigation
(c) Radiation protection – optimising protocols 
to minimise risk, preventing unnecessary or 
duplicate studies.
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(b) Detection
(a) Population-based screening programs
(b) Identification of abnormalities accounting for 
clinical presentations
(c) Diagnosis
(a) Disease staging, facilitating decisions about 
appropriate management
(b) Provision of high-level subspecialist imaging 
interpretation, shown to improve staging and 
management decision-making [21]
(c) Image-guided lesion biopsy for histopathology
(d) Clinical decision-support – facilitating the 
choice of the most-helpful and most-targeted 
investigation to answer a clinical question and 
indicating clinical situations in which imaging 
is likely to represent low-value care.
(d) Delivery and monitoring of therapy
(a) Evaluation of patient progress during treat-
ment; early treatment monitoring (responders 
vs. non-responders)
(b) Development & utilisation of imaging biomark-
ers, to facilitate earlier disease detection, pre-
diction of response to treatment, reduction in 
invasive testing and improvements in targeted 
treatments. Imaging biomarkers add value to 
pre-treatment workup, treatment choice and 
follow-up for many conditions. Biomarkers 
can act as surrogate endpoints in clinical trials, 
leading to more rapid translation of research to 
clinical practice [22].
(c) Interventional radiology – minimally-invasive 
investigations and treatments, often resulting 
in speedier recovery than after formal surgery
(e) Prognosis
(a) Confirmation of disease resolution, facilitating 
cessation of treatment
(f ) Other
(a) Teleradiology linking rural communities and 
highly specialised radiology centres/hospitals
(b) Other non-interpretive activities, e.g. teaching, 
multi-disciplinary team meeting preparation 
and participation, research and administrative 
work [23]
(c) Communication to patients, the public, the 
medical community and other interested stake-
holders. This includes critical test result notifi-
cations to ensure timely clinical handover and 
emergency care [1].
How is value measured?
Impacting therapeutic decisions, improving patient out-
comes and benefits for society as a whole are the core 
aspects of value creation in radiology. Quantifying radi-
ology’s impact requires more precise, reproducible, and 
practically-measurable imaging-specific and clinically-
relevant metrics linked to agreed and important health 
outcomes. Future radiology research must place greater 
emphasis on Fryback and Thornbury’s higher-level out-
comes [11] to best demonstrate radiology’s value. While 
a diagnostic test such as breast MRI, performed using the 
same equipment, scanning parameters, and interpreter, 
may have equivalent diagnostic performance in two dif-
ferent patient groups, its efficacy will likely be greater in 
women with specific characteristics (e.g. BRCA1 muta-
tion carriage).
To whom is the value of radiology delivered?
Ultimately, the recipient of healthcare services (and 
value) is the patient, and, to some extent, their loved 
ones.  However, except in the context of screening, 
requests for diagnostic radiology studies usually come 
from referring clinicians who seek radiology’s input, and 
directly receive the output (reports). Referring clinicians 
can be considered as “intermediate customers”. When 
optimally utilised, the value of radiology is also delivered 
to hospitals and health services and to the economy as a 
whole [1].
Patients do not want an ultrasound, CT, or MRI; they 
want an answer to a clinical question. The primary 
purpose of diagnostic radiology is to answer clinical 
questions using medical imaging, and to help guide 
patient care in the most effective way possible, includ-
ing in some instances not performing an imaging test 
[1]. Fundamentally, diagnostic radiology is concerned 
with acquisition, utilisation, and dissemination of infor-
mation [1]. Process metrics can be used to measure 
aspects of value delivery including timeliness of infor-
mation delivery, application of appropriate levels of 
specialisation to interpretation (and thus to accuracy of 
information acquisition), and tailoring of information 
delivery to the needs of different types of intermedi-
ate customers (e.g. emergency care, primary care, non-
urgent specialty care) [19].
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What is the goal?
Radiology is a key component of healthcare, impacting 
greatly on patient outcomes, and must be considered a 
vital element of VBH. Radiology must be part of any cal-
culation of value metrics, and resourcing decisions based 
on such calculations must take account of the need to 
resource radiology adequately to maintain its value con-
tribution [15].
Radiologists and radiology departments have a respon-
sibility to help define and create value wherever possible 
and to optimise the yield from what we do. In addition, 
we need to publish research reporting on radiology’s 
impact on therapeutic decisions, patient outcomes, and 
societal benefits, especially when targeting select patient 
populations for new medical imaging applications, when 
associated healthcare costs may be large [15]. Traditional 
radiology research metrics like diagnostic and technical 
accuracy may be sufficient to demonstrate a value contri-
bution for tests and procedures with smaller, well-defined 
target populations and/or clear impacts on patient out-
come [15]. When assessing the societal value of radiol-
ogy, we need different robust, reproducible, and clinically 
relevant outcome metrics to objectify and quantify the 
value contributed by radiology [24].
Steps which can support this endeavour include:
1 Engaging directly and often with referring clinicians 
to better understand their practices and needs, and 
to develop mutual relationships of trust and under-
standing.
(a) Supporting evidence-based guidelines to assist 
referrers in requesting appropriate imaging 
or interventional procedures specific to the 
patient’s clinical history or condition (e.g., ESR 
iGuide, ACR Appropriateness Criteria, Choos-
ing Wisely) [25–28].
(b) Reinforcing the use of such guidelines in col-
laboration with referrers enhances the quality 
of patient care and enables radiologists to con-
tribute value through efficacious resource use.
2 Understanding the varying needs of referrers (e.g. 
rapid turnaround, 24/7 availability for emergency 
care, subspecialty expertise, multidisciplinary input 
for complex, non-emergency cases), and building 
services to encompass all needs without conflict [1].
3 Ensuring that radiology departments work cohesively 
as a whole, operating as teams to ensure enterprise-
wide standards are achieved, cross-cover and -sup-
port are freely available, and isolated silos do not 
develop to the detriment of other areas of service.
4 Structuring department work plans to meet referrers’ 
needs, e.g. making protected time available for multi-
disciplinary team activity.
5 Utilising available resources and tools (e.g. structured 
reporting, clinical decision support tools, AI tools) 
and, where possible, augmenting resources to opti-
mise workflow to minimise patient waiting times for 
studies, and (if achievable) shorten hospital stays
6 Engaging directly with patients, to answer their ques-
tions and offer explanation of their imaging findings, 
as appropriate [1].
7 Optimising information (images, reports etc.) 
exchange using appropriate IT tools, e.g. provision of 
urgent report notifications, clinical decision support 
tools and use of structured reporting, including links 
to key images demonstrating positive findings [29].
8 Constant quality monitoring and promotion of a cul-
ture of constant quality improvement [19].
9 Experimental research, including efforts to establish 
higher-level value contributions: supporting today’s 
radiology research is a commitment to improving 
tomorrow’s radiology practice [30].
These principles are inherent to several value-based 
imaging initiatives, including the ACR’s Imaging 3.0 [31], 
the RSNA’s Radiology Cares [32], and the RANZCR’s 
Inside Radiology [33]. Optimisation of value-creation 
and resource utilisation demands cooperation among 
all those involved, including referrers, patients, health-
care administrators, and radiologists. Patients must 
understand that their specific needs are best served by 
a flexible, responsive healthcare system that applies the 
investigation best suited to answering the relevant clini-
cal question at that particular point in their care, with the 
greatest safety. Referrers must work with radiologists to 
optimise resource utilisation, justified and optimised to 
the specific patient’s circumstance at the time, in order 
to maximise value. All parties must educate themselves 
about methodologies used to determine costs and value, 
and must understand that their choice of actions and 
decisions may have influences that go far beyond the nar-
row specifics of any one episode of patient care or siloed 
departmental or hospital budgets. Cost calculation and 
allocation is complex and relative, depending on the ref-
erence points used [17].
Conclusion
VBH as a concept is here to stay. It will underpin future 
planning and resource allocation in all aspects of medi-
cal care. Models of defining value remain in evolution. 
Narrow models which commence the consideration of 
value with the making of a diagnosis are incomplete, and 
misrepresent the entire healthcare resource allocation 
Page 7 of 8Brady et al. Insights Imaging          (2020) 11:136  
for that patient. Radiology’s contribution to healthcare 
is broad, encompassing many aspects that go beyond 
traditional study report creation. Objectifying this con-
tribution by stating the impact on therapeutic deci-
sions, patient outcomes, and societal benefits ensures 
radiologists’ future role. Radiologists, working singly 
or as parts of collective departments, must understand 
the principles underpinning cost allocation and the 
value-chain concept, and must take VBH into account 
when planning, developing and delivering their services. 
Equally, referrers, who impose costs without incurring 
them directly (by utilising services which are paid for by 
patients or third party payers) must have greater account-
ability for their impact on the cost of medical imag-
ing and for ensuring resources are utilised for optimum 
patient health benefit. Managers who resource and plan 
healthcare services must understand how under-resourc-
ing of potential bottlenecks in service delivery, such as 
radiology facilities, can impact negatively on outcomes 
for patients. By embracing VBH principles, and striving 
to create value where possible, radiology can contrib-
ute greatly to moving from a volume-driven system to a 
value-driven one, where as many investigations or inter-
ventions as possible contribute positively to patient out-
comes [1]. This will require renewed willingness on the 
part of radiologists to participate in team-based clini-
cal decision-making with other specialists. It will also 
require willingness on the part of referrers to work with 
radiologists to ensure the most appropriate use of radiol-
ogy resources, services and personnel [1].
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